Skip to Main Content

Paper Details

Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
ArXiv
0
2023
COVID, COVID-19, CoV, SARS, SARS-, SARS-CoV, SARS-CoV-2, mRNA, nucleic acids, people
Author NameAffiliation
Halie M RandoUniversity of Pennsylvania, University of Colorado Anschutz School of Medicine, United States of America Center for Health AI, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 4552) the National Human Genome Research Institute (R01 HG010067).
Ronan LordanInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, University of Pennsylvania Philadelphia
Alexandra J LeeUniversity of Pennsylvania, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 2).
Alexandra J LeeUniversity of Pennsylvania, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 2).
Amruta NaikChildren's Hospital of Philadelphia
Nils WellhausenUniversity of Pennsylvania
Elizabeth SellPerelman School of Medicine, University of Pennsylvania
Likhitha KollaPerelman School of Medicine, University of Pennsylvania, United States of America Funded by NIH Medical Scientist Training Program T32 GM07170.
Anthony GitterUniversity of Wisconsin-Madison, United States of America Morgridge Institute for Research, United States of America Funded by John W. and Jeanne M. Rowe Center for Research in Virology.
Casey S GreeneUniversity of Pennsylvania, Alex's Lemonade Stand Foundation, University of Colorado Anschutz School of Medicine, United States of America Center for Health AI, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 4552) the National Human Genome Research Institute (R01 HG010067).
  • 1 - 10

Datasets